BACKGROUND Early diagnosis of colorectal cancer is associated with a good prognosis and uncovering the biological mechanisms underlying pathogenesis and progression of this cancer form the recent focus of research. E-cadherin is one of the strong intercellular adhesion molecules in epithelial cells and one of the best characterized markers of epithelial-mesenchymal transition. The objectives of this study were to assess the pattern of expression of E-cadherin in colorectal cancer in patients from a medical college in Kerala, India and also determine the association between the expression of E-cadherin and different morphological parameters as well as the grade and stage of the tumour. METHODS All specimens of histologically diagnosed colorectal cancers received in the department were included in the study. Immunohistochemical staining of formalinfixed paraffin-embedded tissue was done. The intensity of E-cadherin staining was scored and analyzed for different tissues. Frequency tables of different variables were analyzed using the chi-square test. The significance of the correlation between different variables was assessed using Fischer’s exact test. P-value < 0.05 was considered statistically significant. RESULTS A total of 43 specimens of histologically diagnosed colorectal cancers were analyzed for the study. The mean age of the participants was 58 years. Majority of the tumours were < 5 cm in size. Both homogenous (55.8 %) and heterogeneous staining (44.2 %) were noted in the E-cadherin staining pattern among the participants. In patients with low E-cadherin index, 12 of them showed a heterogeneous pattern of expression. E-cadherin expression was not statistically associated with tumour differentiation in the patients. CONCLUSIONS There is a significant difference in E-cadherin expression between low and highgrade tumours of colorectal cancer. High-grade tumours showed a more heterogeneous staining pattern correlating with increased invasiveness of the tumour. The heterogeneous pattern of staining in E-cadherin among adjacent cells of tumour results from reduced expression of the protein in the tumour. KEY WORDS E cadherin, Colorectal Cancer, Cancer Marker.
BACKGROUND Bcl-2 gene is an apoptotic protein that blocks apoptosis and thereby its over expression contributes to neoplastic transformation and decreased tumour survival. So, it is necessary to find out the relationship of Bcl-2 expression with histological types and tumour grade in ovarian surface epithelial tumours, which may predict the prognosis. METHODS The objective was to study the expression of Bcl-2 in ovarian surface epithelial tumours and to correlate Bcl-2 expression with histopathological features and tumour grade in ovarian surface epithelial tumours. Histological types and tumour differentiation for each case is determined from the routine H and E sections. Immunohistochemical stain for Bcl-2 was done. Then intensity and extent of staining for Bcl-2 was compared with the age, histological type and tumour grade. RESULTS Out of the 47 cases studied, 66% were in <55 years of age category and 34% in >55 years of age group. There was statistically significant associations of Bcl-2 expression with various histological types (P<0.001) and tumour differentiation (P<0.001). In the case of extent of Bcl-2 staining, statistically significant associations were present with various histological types (P=0.004) and tumour differentiation (P<0.001). CONCLUSIONS Bcl-2 expression decreases with tumour progression. Poorly differentiated tumours with decreased Bcl-2 expression may be helpful in predicting disease progression. Further studies are warranted since, Bcl-2 expression may be important for prognostic outcome or provide useful targets for therapeutic intervention in patients with surface epithelial ovarian cancers. KEY WORDS Bcl-2, Immunohistochemistry, Tumour Grade, Epithelial Tumours.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.